Adaptive pH-Sensitive Liposome Compositions for Specialized Environments

Publication ID: 24-11857509_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive pH-Sensitive Liposome Compositions for Specialized Environments,” Published Technical Disclosure No. 24-11857509_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857509_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,509.

Summary of the Inventive Concept

The present inventive concept relates to specialized pH-sensitive liposome compositions adapted for specific operational environments, including high-security needs, disaster relief, extreme weather conditions, high-altitude environments, and space exploration settings.

Background and Problem Solved

The original patent disclosed pH-sensitive liposome compositions for delivering molecules to cells. However, these compositions were not designed to address the unique challenges and requirements of specialized environments. The present inventive concept addresses this limitation by providing adaptive pH-sensitive liposome compositions tailored to specific operational environments, ensuring efficient and targeted delivery of therapeutic molecules.

Detailed Description of the Inventive Concept

The new inventive concept encompasses pH-sensitive liposome compositions comprising a lipid bilayer substantially free of pHLIP polypeptide. These liposomes are designed to fuse with cell membranes or endosomal compartments in response to specific pH ranges, temperature ranges, oxygen levels, or radiation levels, depending on the target environment. For example, in high-security environments, the liposomes are adapted to fuse with cell membranes at a specific pH range, ensuring secure and targeted delivery of therapeutic molecules. In disaster relief settings, the liposomes are designed to release therapeutic molecules in response to a low pH microenvironment. Similarly, in extreme weather conditions, the liposomes are adapted to deliver cargo molecules in response to specific temperature ranges.

Novelty and Inventive Step

The new inventive concept introduces a novel and non-obvious adaptation of pH-sensitive liposome compositions to specialized operational environments, providing a unique solution for efficient and targeted delivery of therapeutic molecules in these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include liposomes adapted for other specialized environments, such as tropical or desert environments, or liposomes designed to respond to other environmental stimuli, such as electromagnetic fields or vibrations.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including pharmaceuticals, biotechnology, and defense. The targeted delivery of therapeutic molecules in specialized environments could revolutionize the treatment of diseases and improve public health in these settings.

CPC Classifications

SectionClassGroup
A A61 A61K9/1271
A A61 A61K9/127
A A61 A61K31/20
A A61 A61K31/337
A A61 A61K31/704
A A61 A61K31/711
A A61 A61K31/713
A A61 A61K31/7105
A A61 A61K47/6911
A A61 A61P35/00

Field of Art

Pharmaceutical drug delivery systems, specifically liposomal compositions for targeted molecular transport, with expertise in pH-sensitive carrier technologies and cellular membrane interaction mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A skilled researcher with advanced degrees in pharmaceutical sciences, biochemistry, or biomedical engineering, possessing knowledge of liposomal drug delivery, membrane interactions, and environmental responsive molecular transport systems

Obviousness Rationale

A PHOSITA would recognize that adapting pH-sensitive liposome compositions to specialized environments represents a predictable extension of the source patent's core technology of targeted molecular delivery. The fundamental mechanism of pH-triggered membrane interaction remains consistent across the variations, with environmental context serving as a mere design parameter. The technical principles of cargo delivery and membrane fusion disclosed in US 11857509 provide a clear framework for implementing similar strategies in diverse operational contexts.

Obvious Combinations & Variations

Source Patent Element
pH-triggered liposome fusion with cell membranes using pHLIP polypeptide
PTD Variation
Adapting liposome fusion mechanisms to high-security, disaster relief, and extreme environmental contexts
Obviousness Reasoning
Modifying delivery parameters based on environmental conditions represents a routine design optimization for a PHOSITA, utilizing known membrane interaction principles
Source Patent Element
Cargo delivery through liposomal systems targeting specific cellular microenvironments
PTD Variation
Extending delivery mechanisms to respond to temperature, oxygen levels, and radiation exposure
Obviousness Reasoning
Expanding trigger mechanisms for molecular transport is a predictable variation using known responsive material design techniques
Source Patent Element
Lipid bilayer composition substantially free of pHLIP polypeptide
PTD Variation
Creating specialized liposome compositions for diverse operational environments
Obviousness Reasoning
Selecting lipid bilayer configurations to optimize performance in specific contexts represents a standard engineering approach with expected results
Source Patent Element
Targeted cellular delivery of therapeutic molecules
PTD Variation
Implementing delivery strategies for high-altitude and space exploration scenarios
Obviousness Reasoning
Adapting molecular transport technologies to extreme environments is a foreseeable application of established drug delivery principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857509 and the disclosed variations, a person of ordinary skill in the art would find the claimed liposomal delivery systems for specialized environments obvious and lacking inventive step. The technical variations represent predictable modifications to established pH-sensitive molecular transport mechanisms, thereby rendering potential claims in this domain unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,509
TitleLiposome compositions and methods of use thereof
Assignee(s)Yale University, University of Rhode Island Board of Trustees